Navigation Links
Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Date:5/5/2011

, Novartis Oncology. "This is the third indication for Afinitor in the US in just over two years, providing further evidence that inhibiting mTOR plays an important role in treating multiple tumor types."

Afinitor targets mTOR, a protein that acts as an important regulator of tumor cell division, blood vessel growth and cell metabolism(7). Preclinical and clinical data have established the role of mTOR in the development and progression of several types of tumors, including advanced pancreatic NET(1),(7).

About neuroendocrine tumors of pancreatic origin (pancreatic NET)Neuroendocrine tumors arise from cells that can produce and secrete a variety of hormones that regulate bodily functions(8). These tumors can occur anywhere in the body; however, most are found in the pancreas (pancreatic NET), gastrointestinal tract or lungs (carcinoid tumors)(6),(9). Pancreatic NET, also known as islet cell tumors, is a rare type of cancer different from pancreatic exocrine cancer, which is generally referred to as pancreatic cancer(3),(10). There have been limited treatment options for patients with pancreatic NET(2).

About RADIANT-3RADIANT-3 is a Phase III prospective, double-blind, randomized, parallel group, placebo-controlled, multicenter study. The trial examined the efficacy and safety of Afinitor plus best supportive care (BSC) versus placebo plus BSC in 410 patients with advanced, low- or intermediate-grade pancreatic NET. Patients who met the study entry criteria were randomized 1:1 to receive either Afinitor 10 mg once-daily (n=207) or daily placebo (n=203) orally, both in conjunction with BSC(1).

The primary endpoint of RADIANT-3 is progression-free survival. Secondary endpoints include safety, objective response rate (confirmed according to RECIST), duration of response and overall survival(1).

About Afinitor (everolimus)Afinitor® (everolimus) tablets is approved in the US for the treatment of progressive neuroe
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
2. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
3. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
4. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
5. Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients
6. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
7. Final Approval of Novartis Gender Discrimination Settlement Slated for November 19
8. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
9. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Novartis to Expand Global Research Headquarters in Cambridge, MA
11. VIDEO From thenewsmarket.com and Novartis: Phase III Data Show That Novartis Meningococcal Vaccine Menveo® Demonstrated Robust Immunogenicity in Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... N.C. , Nov. 25, 2014  At the ... Antonio this October, KaVo Kerr Group was ... Technology Expo, offering attendees the opportunity to see and ... well-respected key opinion leaders deliver lectures on the latest ... Group products include the new DEXIS CariVu Caries Detection ...
(Date:11/26/2014)... 25, 2014  Medtronic,s roughly $43 billion ... widely discussed in the media for its US ... stronger leading player in one of the fastest ... healthcare market research firm said  the two companies ... diverse set of solutions spanning inpatient to home ...
(Date:11/26/2014)... 25, 2014  Unilife Corporation (NASDAQ: UNIS, ASX: UNS), ... systems, today announced that its Chairman and CEO, ... Piper Jaffray 26th Annual Healthcare Conference at the New ... December 2, 2014. The conference presentation ... listen only Webcast. To listen, please go to: ...
Breaking Medicine Technology:KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2
... 2011 Astellas Pharma Inc. (TSE: 4503) ... to conduct, in conjunction with executive management, a review of ... Prosidion was acquired as part of Astellas, acquisition of OSI ... two drug candidates in development for diabetes and obesity, as ...
... Calif., Jan. 10, 2011 Questcor Pharmaceuticals, Inc. ... to 2010.  The Company estimates that 353 new, paid Acthar ... and shipped during the quarter, up 66% from the year ... 2010.  1,680 vials and 6,666 vials of the company,s principal ...
Cached Medicine Technology:Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary 2Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary 3Questcor Pharmaceuticals Reports Strong Finish to 2010 2Questcor Pharmaceuticals Reports Strong Finish to 2010 3Questcor Pharmaceuticals Reports Strong Finish to 2010 4Questcor Pharmaceuticals Reports Strong Finish to 2010 5
(Date:11/26/2014)... 27, 2014 AlignLife, a chiropractic ... the kick-off of its annual Toy Drive. With ... go to donate to those in need throughout ... organizations to distribute the donations to those most ... locations will be accepting donations at the clinics ...
(Date:11/26/2014)... November 27, 2014 Recently, DressVe ... special occasion dresses, has unveiled its 2014 Cyber Monday ... these new dresses, up to 90 percent off. The ... Dec. 3. Free delivery is provided for orders above ... women’s dresses, shoes, handbags and other fashion accessories. The ...
(Date:11/26/2014)... 27, 2014 Boxing Day is traditionally ... would receive gifts, known as a "Christmas box", from ... , With the coming of Boxing Day, some people ... smart before every business opportunity, and it has recently ... a site-wide promotion for its global customers. Then people ...
(Date:11/26/2014)... Norwalk Hospital is pleased to ... by the American Nurses Credentialing Center (ANCC). , ... of work environments where nurses can flourish. The ... Norwalk Hospital and identifies it as one of ... an organizations’ commitment to nurses and their contributions ...
(Date:11/26/2014)... Alex Kramer HealthDay ... People with rheumatoid arthritis may be more likely to achieve ... new research. The study found that those who were ... Being underweight also lowered the odds of remission. "Medication ... population," said Dr. Susan Goodman, the study,s lead author and ...
Breaking Medicine News(10 mins):Health News:DressVe.com: Best 2014 Special Monday Sales Online 2Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 3Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3
... students and junior medical doctors of the Medical College ... have decided to not to run the outpatient departments ... doctors have however promised not to cause any inconvenience ... a ‘parallel OPD’s’ for the benefit of patents. A ...
... substance inside the body of a lobster commonly known as ... may others as a waste//, unhealthy product. The health agency ... eating too much of lobster tomalley. ,The health ... as a liver and pancreas for lobster, can sometimes contain ...
... anti-reservation medicos strike in India, the government on Sunday night ... on quota in central educational institutes// but the students and ... by calling a bandh in Delhi on May 31. ... talks with Federal Minister Oscar Fernandes who followed it up ...
... issue has been put on the national agenda by India's ... more pressing problems. // ,Sam Pitroda was right ... selecting students for institutions of higher education. But his suggested ... (IITs) is not feasible. Already, the existing IITs are facing ...
... The new interim head of the World Health Organization (WHO), ... since assuming office // , confirmed that Dr Anders Nordstrom. ... the support from the people to continue the fight against ... would continue the work of his predecessor Dr Lee Jong-wook, ...
... AIDS. It is waiting for the FDA to give it ... Nasdaq-listed company already sells the kit to hospitals and public ... product would become an important weapon to fight against HIV. ... was made. Statistics show that more than one million Americans ...
Cached Medicine News:Health News:Agitating Doctors Call For Two Day Shut Down Of OPD’ 2Health News:Quota System: Diverting Attention From The Real Problem 2Health News:Quota System: Diverting Attention From The Real Problem 3Health News:Quota System: Diverting Attention From The Real Problem 4
... Biotechnology, Genomic and Proteomic users should ... over Sample Preparation capability for run-to-run ... ventilated centrifuge accommodates 4x750 ml up ... throughput. High throughput screening, research and ...
... common sight in laboratories everywhere, Model ... dependable centrifuge standards for decades in ... Model K's simple, classic design and ... a standard for centrifuge performance, reliability ...
Inquire...
... Use of the Hybridization Oven/Shaker rigidly ... ensuring the stringency of hybridization and ... and reproducible probing of nucleic acids ... Developed for use with radioactive and ...
Medicine Products: